1. Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective review. (June 2017) Authors: Al-Sawaf, Othman; Cramer, Paula; Goede, Valentin; Hallek, Michael; Pflug, Natali Journal: Therapeutic advances in hematology Issue: Volume 8:Number 6(2017) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia. (9th February 2016) Authors: Maurer, Christian; Pflug, Natali; Bahlo, Jasmin; Kluth, Sandra; Rhein, Christina; Cramer, Paula; Gross‐Ophoff, Carolin; Langerbeins, Petra; Fink, Anna‐Maria; Eichhorst, Barbara; Kreuzer, Karl‐Anton; Fischer, Norbert; Tausch, Eugen; Stilgenbauer, Stephan; Böttcher, Sebastian; Döhner, Hartmut; Kneb... Journal: European journal of haematology Issue: Volume 97:Number 3(2016:Sep.) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota. (2nd June 2016) Authors: Pflug, Natali; Kluth, Sandra; Vehreschild, Jörg J.; Bahlo, Jasmin; Tacke, Daniela; Biehl, Lena; Eichhorst, Barbara; Fischer, Kirsten; Cramer, Paula; Fink, Anna-Maria; von Bergwelt-Baildon, Michael; Stilgenbauer, Stephan; Hallek, Michael; Cornely, Oliver A.; Vehreschild, Maria J. G. T. Journal: Oncoimmunology Issue: Volume 5:Number 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine–mitoxantrone–cyclophosphamide–alemtuzumab induction followed by alemtuzumab maintenance. Issue 3 (23rd February 2019) Authors: Pflug, Natali; Cramer, Paula; Robrecht, Sandra; Bahlo, Jasmin; Westermann, Anne; Fink, Anna-Maria; Schrader, Alexandra; Mayer, Petra; Oberbeck, Sebastian; Seiler, Till; Zenz, Thorsten; Dürig, Jan; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Herling, Marco; Hop... Journal: Leukemia & lymphoma Issue: Volume 60:Issue 3(2019) Page Start: 649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Obinutuzumab in Allogeneic Transplantation for CLL and Richter's Transformation in the Age of Targeted Therapies. Issue 12 (12th December 2021) Authors: Pflug, Natali; Chakupurakal, Geothy; Fink, Anna-Maria; Robrecht, Sandra; Herling, Marco; Cramer, Paula; Holtick, Udo; Theurich, Sebastian; Schetelig, Johannes; Fischer, Kirsten; Ritgen, Matthias; Scheid, Christof; Eichhorst, Barbara; Dreger, Peter; Hallek, Michael; von Bergwelt-Baildon, Michael Other Names: other. Journal: HemaSphere Issue: Volume 5:Issue 12(2021) Page Start: e664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Second-line therapies of patients initially treated with fludarabine and cyclophosphamide or fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia within the CLL8 protocol of the German CLL Study Group. Issue 8 (August 2013) Authors: Cramer, Paula; Fink, Anna-Maria; Busch, Raymonde; Eichhorst, Barbara; Wendtner, Clemens-Martin; Pflug, Natali; Langerbeins, Petra; Bahlo, Jasmin; Goede, Valentin; Schubert, Friederike; Döhner, Hartmut; Stilgenbauer, Stephan; Dreger, Peter; Kneba, Michael; Böttcher, Sebastian; Mayer, Jiri; Hallek,... Journal: Leukemia & lymphoma Issue: Volume 54:Issue 8(2013:Aug.) Page Start: 1821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T‐cell prolymphocytic leukemia. Issue 12 (19th March 2013) Authors: Hopfinger, Georg; Busch, Raymonde; Pflug, Natali; Weit, Nicole; Westermann, Anne; Fink, Anna‐Maria; Cramer, Paula; Reinart, Nina; Winkler, Dirk; Fingerle‐Rowson, Günter; Stilgenbauer, Stephan; Döhner, Hartmut; Kandler, Gabriele; Eichhorst, Barbara; Hallek, Michael; Herling, Marco Journal: Cancer Issue: Volume 119:Issue 12(2013) Page Start: 2258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T‐cell prolymphocytic leukemia. Issue 12 (19th March 2013) Authors: Hopfinger, Georg; Busch, Raymonde; Pflug, Natali; Weit, Nicole; Westermann, Anne; Fink, Anna‐Maria; Cramer, Paula; Reinart, Nina; Winkler, Dirk; Fingerle‐Rowson, Günter; Stilgenbauer, Stephan; Döhner, Hartmut; Kandler, Gabriele; Eichhorst, Barbara; Hallek, Michael; Herling, Marco Journal: Cancer Issue: Volume 119:Issue 12(2013) Page Start: 2258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The CLL12 trial protocol: a placebo-controlled double-blind Phase III study of ibrutinib in the treatment of early-stage chronic lymphocytic leukemia patients with risk of early disease progression. (July 2015) Authors: Langerbeins, Petra; Bahlo, Jasmin; Rhein, Christina; Cramer, Paula; Pflug, Natali; Fischer, Kirsten; Stilgenbauer, Stephan; Kreuzer, Karl Anton; Wendtner, Clemens-Martin; Eichhorst, Barbara; Hallek, Michael Journal: Future oncology Issue: Volume 11:Number 13(2015) Page Start: 1895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗